These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effects of some analgesics and antidepressants on the (Na + + K + )-adenosine triphosphatase from cortices of brain and kidney. Medzihradsky F; Nandhasri PS Biochem Pharmacol; 1972 Aug; 21(15):2103-9. PubMed ID: 4264878 [No Abstract] [Full Text] [Related]
28. Adenosine triphosphatase from rat liver mitochondria. I. Purification, homogeneity, and physical properties. Catterall WA; Pedersen PL J Biol Chem; 1971 Aug; 246(16):4987-94. PubMed ID: 4255092 [No Abstract] [Full Text] [Related]
29. Interaction of kidney (Na + -K + )-ATPase with phospholipid model membrane systems. Sood CK; Sweet C; Zull JE Biochim Biophys Acta; 1972 Sep; 282(1):429-34. PubMed ID: 4262696 [No Abstract] [Full Text] [Related]
30. Properties of sodium and potassium activated adenosine triphosphatases of rat brain: effect of cyclopropane and other agents modifying enzyme activity. NRDL-TR-68-127. Trevor AJ; Cummins JT Res Dev Tech Rep; 1968 Nov; ():1-22. PubMed ID: 4239289 [No Abstract] [Full Text] [Related]
32. Separation of adenosine diphosphate--adenosine triphosphate-exchange activity from the cerebral microsomal sodium-plus-potassium ion-stimulated adenosine triphosphatase. Stahl WL; Sattin A; McIlwain H Biochem J; 1966 May; 99(2):404-12. PubMed ID: 4223577 [TBL] [Abstract][Full Text] [Related]
33. Partial resolution of the enzyme catalyzing oxidative phosphorylation. XXII. Interaction between mitochondrial adenosine triphosphatase inhibitor and mitochondrial adenosine triphosphatase. Horstman LL; Racker E J Biol Chem; 1970 Mar; 245(6):1336-44. PubMed ID: 4245874 [No Abstract] [Full Text] [Related]
34. Structue-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. I. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of magnesium and phosphate. Yoda A Mol Pharmacol; 1973 Jan; 9(1):51-60. PubMed ID: 4265446 [No Abstract] [Full Text] [Related]
35. Chemical modification of a cerebral sodium-plus-potassium ion-stimulated adenosine triphosphatase preparation. Pull I Biochem J; 1970 Sep; 119(3):377-85. PubMed ID: 4250847 [TBL] [Abstract][Full Text] [Related]
36. A simple and rapid method for the reversible removal of lipids from a membrane-bound enzyme. Goodman SL; Isern de Caldentey M; Wheeler KP Biochem J; 1978 Feb; 169(2):305-11. PubMed ID: 147078 [TBL] [Abstract][Full Text] [Related]
37. An allosteric explanation for ouabain-induced time-dependent inhibition of sodium, potassium-adenosine triphosphatase. Allen JC; Lindenmayer GE; Schwartz A Arch Biochem Biophys; 1970 Nov; 141(1):322-8. PubMed ID: 4249246 [No Abstract] [Full Text] [Related]
38. Purification and some properties of Na,K-transport ATPase. I. Solubilization and stability of Lubrol extracts. Nakao T; Nakao M; Mizuno N; Komatsu Y; Fujita M J Biochem; 1973 Mar; 73(3):609-19. PubMed ID: 4269266 [No Abstract] [Full Text] [Related]
39. Studies on the reaction catalyzed by transport (Na, K) adenosine triphosphatase. I. Effects of divalent metals. Hexum TD Biochem Pharmacol; 1974 Dec; 23(24):3441-7. PubMed ID: 4280311 [No Abstract] [Full Text] [Related]
40. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. 3. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate. Yoda A; Yoda S Mol Pharmacol; 1974 May; 10(3):494-500. PubMed ID: 4277671 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]